Evidence map›Paper›PMID 30728818›Full record

ArticleFrontiers in microbiology2018

Asprellcosides B of

Wen Zhang, Si-Tai Chen, Qiu-Yan He, Li-Quan Huang, Xiong Li, Xiao-Ping Lai, Shao-Feng Zhan, Hui-Ting Huang, Xiao-Hong Liu, Jianguo Wu and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Antiviral and Cytotoxic Activities ofMolecules (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Article
  6. Ethnobotanical Survey on Bitter Tea in Taiwan.Frontiers in pharmacology · 2022
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Wen ZhangLaboratory Animal Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Si-Tai ChenLaboratory Animal Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Qiu-Yan HeLaboratory Animal Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Li-Quan HuangThe First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Xiong LiGuangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, China.
Xiao-Ping LaiLaboratory Animal Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Shao-Feng ZhanThe First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Hui-Ting HuangThe First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Xiao-Hong LiuLaboratory Animal Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Jianguo WuKey Laboratory of Virology, Institute of Medical Microbiology, Jinan University, Guangzhou, China.
Geng LiLaboratory Animal Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Guangzhou University of Chinese Medicine · CNFirst Affiliated Hospital of Guangzhou University of Chinese Medicine · CNGuangdong Academy of Medical Sciences · CNJinan University · CNZhejiang Chinese Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-influenza activitycompetitive inhibitionhemagglutinin (HA) proteinIlex asprellainhibition of membrane fusiontriterpenoid saponins sulfate

Identifiers

PMID30728818
PMCPMC6351491
OpenAlexW2914238370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.